BayWa’s €2.7 Billion Chasm: A Cash Lifeline Arrives as a Legal Storm Gathers

BayWa must secure €107M from Cefetra sale and a standstill extension by today to avoid unraveling its restructuring plan amid a €2.7 billion financing shortfall.

The clock is ticking for BayWa. By the close of business today, the Munich-based agricultural conglomerate must collect a €107 million payment from the Cefetra sale and secure an extended standstill agreement from its core lenders. Both conditions are make-or-break for a restructuring plan that is already creaking under the weight of a €2.7 billion financing gap.

The cash injection—comprising €45 million from the remaining purchase price and roughly €62 million in repaid shareholder loans—offers a temporary boost to the company’s negotiating hand with DZ Bank and UniCredit/HVB. But it does nothing to solve the structural deficit. The real test lies in whether both banks will agree to extend the standstill pact until autumn 2026. Without that extension, the StaRUG plan finalized last May loses its legal footing, and the entire financing architecture unravels.

A Hole That Keeps Growing

The original blueprint for BayWa’s turnaround relied on selling a 51% stake in its renewable energy arm, BayWa r.e., for up to €1.7 billion. That plan collapsed after the US slashed subsidies for clean energy projects in early 2025. The EBITDA target for BayWa r.e. has since been slashed by roughly 35%—the company now expects €150 million by 2030, rather than the €230 million it had penciled in for 2028.

Of the €4 billion needed by 2028, only €1.3 billion is secured. That leaves a €2.7 billion shortfall. The next disposal on the block is the New Zealand fruit trading unit T&G Global, a process launched in March 2026 with Goldman Sachs as advisor. T&G is operationally sound—it generated $1.3 billion in revenue in 2024—but the sale is being slowed by Hong Kong-based minority shareholder Joy Wing Mau Group. Even if successful, the deal would yield only around €300 million, a drop in the ocean relative to the funding gap.

Shrinking the Ship

BayWa is undergoing a radical downsizing. The internal approval threshold for transactions requiring board consent has been cut from €200 million to €50 million. Three supervisory board members have left or are in the process of departing. Management has scrapped its 2026 guidance and reduced the 2027 EBITDA target to roughly €140 million. By 2028, the group aims to transform from a €24 billion conglomerate into a focused agricultural and building materials trader with around €10 billion in revenue. Around 1,300 jobs are slated for elimination.

The first concrete test of whether cost-cutting is working will come on May 6, when BayWa releases its first-quarter 2026 results. The audited 2025 annual report, however, won’t land until the fourth quarter of 2026 at the earliest.

Legal Pressure Mounts

The company is also fighting a growing legal battle. The Tübingen-based law firm TILP is preparing damages claims on behalf of shareholders, alleging that BayWa misled investors about price-sensitive facts between January 2022 and January 2026. The claims target former board members and potentially auditor PricewaterhouseCoopers. Germany’s financial watchdog BaFin has already criticized the company for failing to disclose material refinancing risks in its 2023 management report, and the Apas regulatory authority has opened a professional oversight procedure. All parties are presumed innocent.

The stock currently trades at around €14.45, roughly 28% below its level 12 months ago. With annualized volatility exceeding 50% and no audited financials until late 2026, BayWa shares remain a high-stakes bet on a restructuring that is still far from assured.